7713 Stock Overview
WeLeader Biomedical Co., Ltd. operates as an agent and distributor of in vitro diagnostic products.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
WeLeader Biomedical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$74.00 |
| 52 Week High | NT$85.00 |
| 52 Week Low | NT$64.70 |
| Beta | 0 |
| 1 Month Change | 2.78% |
| 3 Month Change | 8.50% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -10.30% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7713 | TW Healthcare | TW Market | |
|---|---|---|---|
| 7D | 1.4% | 1.2% | 1.3% |
| 1Y | n/a | -15.0% | 29.2% |
Return vs Industry: Insufficient data to determine how 7713 performed against the TW Healthcare industry.
Return vs Market: Insufficient data to determine how 7713 performed against the TW Market.
Price Volatility
| 7713 volatility | |
|---|---|
| 7713 Average Weekly Movement | 3.1% |
| Healthcare Industry Average Movement | 4.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in TW Market | 8.7% |
| 10% least volatile stocks in TW Market | 2.3% |
Stable Share Price: 7713 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 7713's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | n/a | n/a | www.weleader.com.tw |
WeLeader Biomedical Co., Ltd. operates as an agent and distributor of in vitro diagnostic products. It offers a range of medical testing systems, such as serum biochemistry integration platform, clinical care, and medical information integration system. The company also provides blood gas electrolyte analyzers, urine analyzers, integrated fully automatic biochemical analyzers, fully automatic electronic luminescence immunoassay products, fully automatic modular biochemical immune assay products, TTA automated pre-processing products, POCT central laboratory products, and CCM fully automated track processing products.
WeLeader Biomedical Co., Ltd. Fundamentals Summary
| 7713 fundamental statistics | |
|---|---|
| Market cap | NT$3.08b |
| Earnings (TTM) | NT$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 7713 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7713 income statement (TTM) | |
|---|---|
| Revenue | NT$0 |
| Cost of Revenue | NT$0 |
| Gross Profit | NT$0 |
| Other Expenses | NT$0 |
| Earnings | NT$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 7713 perform over the long term?
See historical performance and comparison